Bay Area drug discovery company Verge Genomics has formed industry and academic alliances in neuro disorders.
CRO lobby group ACRO wants the government to drill down into what tax reform can mean for research.
Aquila BioMedical signed an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.
Bioclinica is looking to broaden its reach with the purchase of MDDX Research & Informatics.
Major CRO player PPD has won a lucrative seven-year government contract in infectious disease.
Germany’s Evotec has penned another deal amid a stream of R&D pacts over the past year, this time with PARP player Tesaro.
Major CRO Parexel has teamed up with tech giant Microsoft to create a new cloud tech alliance, all aimed at speeding up drug research.
Forge Therapeutics and Evotec have launched a discovery platform to develop novel antibiotics targeting metalloenzymes.
A full 14 years after founding CRO Clinipace, its long-standing CEO and president, Jeff Williams, is planning to step down.
As part of our video series for this year’s DDF 2017 event, life science leaders spoke to us about CRO needs and new regulations.